Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.

Vutrisiran can improve and maintain functional capacity and quality of life in patients with transthyretin amyloidosis with ...

A combination of eyelid pressure patching and decellularized, dehydrated pure amniotic membrane basement membrane healed ...

for people with a clinical diagnosis of mild cognitive impairment or mild dementia due to Alzheimer's disease who are APOE4 non-carriers or heterozygotes with confirmed amyloid pathology ...

Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related to Alzheimer's disease in individuals with mild cognitive impairment ...

Women and individuals with a paternal history of Alzheimer disease (AD) have a stronger association between global β-amyloid (Aβ) and tau deposition.

Pantheon Vision, a preclinical-stage medical device company developing bioengineered corneal implants to eliminate corneal blindness, today announced entering a collaboration agreement with ...

Aurion will operate as a separate company with full support from Alcon to advance its clinical-stage allogeneic cell therapy asset, AURN001, into Phase 3 for corneal edema secondary to corneal ...

Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related to Alzheimer's disease in individuals with mild cognitive impairment (MCI) ...